Changes of metabolic profiles in an oral squamous cell carcinoma cell line induced by eugenol

In Vivo

Volumn 27, Issue 2, 2013, Pages 233-243

  Koh, Teho ^a   Murakami, Yukio ^a   Tanaka, Shoji ^a   Machino, Mamoru ^a   Onuma, Hiromi ^b   Kaneko, Miku ^b   Sugimoto, Masahiro ^b,c   Soga, Tomoyoshi ^b   Tomita, Masaru ^b   Sakagami, Hiroshi ^a  

^a MEIKAI UNIVERSITY SCHOOL OF DENTISTRY   (Japan)

^b KEIO UNIVERSITY   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

ATP utilization; Eugenol; Hsc 2 cells; Metabolomics; Non apoptotic cell death; Oral squamous cell carcinoma; Oxidative stress; Polyamine

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; AMINO ACID; EUGENOL; GLUTATHIONE; GLUTATHIONE DISULFIDE; MANNITOL; METHANOL; METHIONINE SULFOXIDE; POLYAMINE; TRICARBOXYLIC ACID;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL COUNT; CELL VIABILITY; CYTOTOXICITY; HUMAN; HUMAN CELL; INCUBATION TIME; METABOLOMICS; MOUTH SQUAMOUS CELL CARCINOMA; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS;

EID: 84876931539     PISSN: 0258851X     EISSN: 17917549     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Sweet C: Procedure for treatment of expoxed and pulpless deciduous teeth. J Am Dent Assoc 17: 1150-1153, 1930.
2. Primosch RE: Primary tooth pulp therapy as taught in predoctoral pediatric dental programs in the United States. Pediatr Dent 19: 118-122, 1997.
3. Hume W: An analysis of the release and the diffusion through dentin of eugenol from zinc oxide-eugenol mixtures. J Dent Res 63: 881-884, 1984.
4. Glass R and Zander H: Pulp healing. J Dent Res 28: 97-107, 1949.
5. Barja-Fidalgo F, Moutinho-Ribeiro M, Oliveira MAA and Oliveira BH: A systemic review of root canal filling materials for deciduous teeth: Is there an alternative for zinc oxideeugenol? ISRN Dentistry Volume 2011, Article ID367318, 7 pages doi:10.5402/2011/367318.
6. Hilton TJ: Keys to clinical success with pulp capping: A review of the literature. Oper Dent 34: 615-625, 2009.
7. Hume WR: Effect of eugenol on respiration and division in human pulp, mouse fibroblasts, and liver cells in vitro. J Dent Res 63: 1262-1265, 1984.
8. Koh T, Machino M, Murakami Y, Umemura N and Sakagami H: Cytotoxicity of dental compounds against human oral squamous cell carcinoma and normal oral cells. In Vivo 27: 85- 96, 2013.
9. Atsumi T, Fujisawa S, Satoh K, Sakagami H, Iwakura I, Ueha T, Sugita Y and Yokoe I: Cytotoxicity and radical intensity of eugenol, isoeugenol or related dimers. Anticancer Res 20: 2519- 2524, 2000.
10. Jaqanathan SK, Mazumdar A, Mondhe D and Mandal M: Apoptotic effect of eugenol in human colon cancer cell lines. Cell Biol Int 35: 607-615, 2011.
11. Vidhya N and Devaraj SN: Induction of apoptosis by eugenol in human breast cancer cells. Indian J Exp Biol 49: 871-878, 2011.
12. Majno G and Joris I: Apoptosis, oncosis, and necrosis. An overview of cell death. Am J Pathol 146: 3-15, 1995
13. Halestrap AP, Clarke SJ and Javadov SA: Mitochondrial permeability transition pore opening during myocardial reperfusion - a target for cardioprotection. Cardiovasc Res 61: 372-385, 2004.
14. Halestrap A: Biochemistry: a pore way to die. Nature 434: 578- 579, 2005.
15. Soga T, Baran R, Suematsu M, Ueno Y, Ikeda S, Sakurakawa T, Kakazu Y, Ishikawa T, Robert M, Nishioka T and Tomita M: Differential metabolomics reveals ophthalmic acid as an oxidative stress biomarker indicating hepatic glutathione consumption. J Biol Chem 281: 16768-16776, 2006.
16. Soga T, Igarashi K, Ito C, Mizobuchi K, Zimmermann HP and Tomita M: Metabolomic profiling of anionic metabolites by capillary electrophoresis mass spectrometry. Anal Chem 81: 6165-6174, 2009.
17. Sugimoto M, Sakagami H, Yokote Y, Onuma H, Kaneko M, Mori M, Sakaguchi Y, Soga T and Tomita M: Non-targeted metabolite profiling in activated macrophage secretion. Metabolomics 8: 624-633, 2012.
18. Sugimoto M, Wong DT, Hirayama A, Soga T and Tomita M: Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancerspecific profiles. Metabolomics 6: 78-95, 2010.
19. Sugimoto M, Kawakami M, Robert M, Soga T and Tomita M: Bioinformatics tools for mass spectroscopy-based metabolomic data processing and analysis. Curr Bioinform 7: 96-108, 2012.
20. Storey JD and Tibshirani R: Statistical significance for genomewide studies. Proc Natl Acad Sci USA 100: 9440-9445, 2003.
21. Saeed AI, Sharov V, White J, Li J, Liang W, Bhagabati N, Braisted J, Klapa M, Currier T, Thiagarajan M, Sturn A, Snuffin M, Rezantsev A, Popov D, Ryltsov A, Kostukovich E, Borisovsky I, Liu Z, Vinsavich A, Trush V and Quackenbush J: TM4: A free, open-source system for microarray data management and analysis. Biotechniques 34: 374-378, 2003.
22. Cobum RF: Polyamine effects on cell function: Possible central role of plasma membrane PI(4,5)P2. J Cell Physiol 221: 544- 551, 2009.
23. Xie LH, John SA, Ribalet B and Weiss JN: Activation of inwardly rectifying potassium (Kir) channels by phosphatidylinositol-4,5- bisphosphate (PIP2): interaction with other regulatory ligands. Prog Biophys Mol Biol 94: 320-335, 2006. in vivo 27: 233-244 (2013)
24. Ho YC, Huang FM and Chang YC: Mechanisms of cytotoxicity of eugenol in human osteoblastic cells in vitro. Int Endod J 39: 389-393, 2006.
25. Yoshiba-Suzuki S, Sagara J, Bannai S and Makino N: the dynamics of cysteine, glutathione and their disulphides in astrocyte culture medium. J Biochem 150: 95-102, 2011.
26. Tarrago L and Gladyshev VN: Recharging oxidative protein repair: catalysis by methionine sulfoxide reductases towards their amino acid, protein, and model substrates. Biochemistry 77: 1097-1107, 2012.
27. Koh T, Murakami Y, Tanaka S, Machino M and Sakagami H: Reevaluation of anti-inflammatory potential of eugenol in IL-1Bstimulated gingival fibroblast and pulp cells. In Vivo 27: in press, 2013.
28. Magalhães CB, Riva DR, DePaula LJ, Brando-Lima A, Koatz VL, Leal-Cardoso JH, Zin WA and Faffe DS: In vivo antiinflammatory action of eugenol on lipopolysaccharide-induced lung injury. J Appl Physiol 108: 845-851, 2010.
29. Bachiega TF, de Sousa JP, Bastos JK and Sforcin JM: Clove and eugenol in noncytotoxic concentrations exert immunomodulatory/ anti-inflammatory action on cytokine production by murine macrophages. J Pharm Pharmacol 64: 610-616, 2012.
30. Fujisawa S, Atsumi T, Satoh K, Kadoma Y, Ishihara M, Okada N, Kashiwagi Y, Yokoe I and Sakagami H: Radical generation, radical-scavenging activity and cytotoxicity of eugenol-related compounds. In Vitro Mol Toxicol 13: 269-279, 2000.
31. Fujisawa S, Atsumi T, Kadoma Y and Sakagami H: Antioxidant and prooxidant action of eugenol-related compounds and their cytotoxicity. Forum "Phenolic compounds: Free radical mechanisms of toxicity, catalysis, and protection". Toxicology 177: 39-54, 2002.
32. Chang YC, Tai KW, Huang FM and Huang MF: Cytotoxic and nongenotoxic effects of phenolic compounds in human pulp cell cultures. J Endod 26: 440-443, 2000.
33. Tanaka S, Machino M, Akita S, Yokote Y and Sakagami H: Changes in salivary amino acid composition during aging. In Vivo 24: 853-856, 2010.
34. Tanaka S, Maehara K, Kaneshima A, Machino M, Onuma H, Kaneko M, Sakagami H, Sugimoto M, Soga T and Tomita M: Pilot study of changes in salivary metabolic profiles induced by template therapy. In Vivo 26: 1015-1020, 2012.